ATP release and purinergic signaling in NLRP3 inflammasome activation

The NLRP3 inflammasome is a protein complex involved in IL-1β and IL-18 processing that senses pathogen- and danger-associated molecular patterns. One step- or two step- models have been proposed to explain the tight regulation of IL-1β production during inflammation. Moreover, cellular stimulation...

Full description

Bibliographic Details
Main Authors: Isabelle eCOUILLIN, Aurelie eGOMBAULT, Ludivine eBaron
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00414/full
_version_ 1818190448202612736
author Isabelle eCOUILLIN
Aurelie eGOMBAULT
Ludivine eBaron
author_facet Isabelle eCOUILLIN
Aurelie eGOMBAULT
Ludivine eBaron
author_sort Isabelle eCOUILLIN
collection DOAJ
description The NLRP3 inflammasome is a protein complex involved in IL-1β and IL-18 processing that senses pathogen- and danger-associated molecular patterns. One step- or two step- models have been proposed to explain the tight regulation of IL-1β production during inflammation. Moreover, cellular stimulation triggers ATP release and subsequent activation of purinergic receptors at the cell surface. Importantly some studies have reported roles for extracellular ATP (eATP), in NLRP3 inflammasome activation in response to PAMPs and DAMPs. In this mini review, we will discuss the link between active ATP release, purinergic signaling and NLRP3 inflammasome activation. We will focus on the role of autocrine or paracrine ATP export in particle-induced NLRP3 inflammasome activation and discuss how particle activators are competent to induce maturation and secretion of IL-1β through a process that involves, as a first event, extracellular release of endogenous ATP through hemichannel opening, and as a second event, signaling through purinergic receptors that trigger NLRP3 inflammasome activation. Finally, we will review the evidence for ATP as a key proinflammatory mediator released by dying cells. In particular we will discuss how cancer cells dying via autophagy trigger ATP-dependent NLRP3 inflammasome activation in the macrophages engulfing them, eliciting an immunogenic response against tumors.
first_indexed 2024-12-11T23:58:52Z
format Article
id doaj.art-0a0b53a918974b99b1fb845ab38c65a1
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T23:58:52Z
publishDate 2013-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-0a0b53a918974b99b1fb845ab38c65a12022-12-22T00:45:17ZengFrontiers Media S.A.Frontiers in Immunology1664-32242013-01-01310.3389/fimmu.2012.0041437774ATP release and purinergic signaling in NLRP3 inflammasome activationIsabelle eCOUILLIN0Aurelie eGOMBAULT1Ludivine eBaron2Centre national de la Recherche Scientifique (CNRS) ORLEANS UniversityUMR-INEM 7355 (ex IEM-UMR6218) Experimental and Molecular Immuno.., CNRS and Orleans University,Orleans University, Centre national de la Recherche Scientifique (CNRS) ORLEANS UniversityThe NLRP3 inflammasome is a protein complex involved in IL-1β and IL-18 processing that senses pathogen- and danger-associated molecular patterns. One step- or two step- models have been proposed to explain the tight regulation of IL-1β production during inflammation. Moreover, cellular stimulation triggers ATP release and subsequent activation of purinergic receptors at the cell surface. Importantly some studies have reported roles for extracellular ATP (eATP), in NLRP3 inflammasome activation in response to PAMPs and DAMPs. In this mini review, we will discuss the link between active ATP release, purinergic signaling and NLRP3 inflammasome activation. We will focus on the role of autocrine or paracrine ATP export in particle-induced NLRP3 inflammasome activation and discuss how particle activators are competent to induce maturation and secretion of IL-1β through a process that involves, as a first event, extracellular release of endogenous ATP through hemichannel opening, and as a second event, signaling through purinergic receptors that trigger NLRP3 inflammasome activation. Finally, we will review the evidence for ATP as a key proinflammatory mediator released by dying cells. In particular we will discuss how cancer cells dying via autophagy trigger ATP-dependent NLRP3 inflammasome activation in the macrophages engulfing them, eliciting an immunogenic response against tumors.http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00414/fullATPNLRP3Inflammasomepurinergic signalingdanger signalP2R
spellingShingle Isabelle eCOUILLIN
Aurelie eGOMBAULT
Ludivine eBaron
ATP release and purinergic signaling in NLRP3 inflammasome activation
Frontiers in Immunology
ATP
NLRP3
Inflammasome
purinergic signaling
danger signal
P2R
title ATP release and purinergic signaling in NLRP3 inflammasome activation
title_full ATP release and purinergic signaling in NLRP3 inflammasome activation
title_fullStr ATP release and purinergic signaling in NLRP3 inflammasome activation
title_full_unstemmed ATP release and purinergic signaling in NLRP3 inflammasome activation
title_short ATP release and purinergic signaling in NLRP3 inflammasome activation
title_sort atp release and purinergic signaling in nlrp3 inflammasome activation
topic ATP
NLRP3
Inflammasome
purinergic signaling
danger signal
P2R
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00414/full
work_keys_str_mv AT isabelleecouillin atpreleaseandpurinergicsignalinginnlrp3inflammasomeactivation
AT aurelieegombault atpreleaseandpurinergicsignalinginnlrp3inflammasomeactivation
AT ludivineebaron atpreleaseandpurinergicsignalinginnlrp3inflammasomeactivation